Loading company…
Noah AI develops analytics and real-time monitoring tools for pharmaceutical research and drug development.
Noah AI provides tools for tracking drug development, analyzing clinical outcomes and accessing information from medical conferences such as ASH and ASCO. Founded in 2023 in Beijing, the company serves drug developers, investors and healthcare professionals. It raised pre-Series A+ funding in December 2025, co-led by HSG and Yijing Investment, with participation from China International Capital Corporation and Sinovation Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in